CEOInterviews.AI
Verified executive transcripts, quotes, and interview insights from CervoMed leadership.
Clinical-stage biotech developing neflamapimod for dementia with Lewy bodies. [BIOTECH-2026-10-04]
Search transcripts, quotes, and verified statements from every CervoMed executive via our platform or API.